Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

Studies a sirolimus-releasing stent in people with coronary artery disease

Observes a sirolimus-releasing heart stent in adults with coronary artery disease needing stent placement.

Key facts

Who runs it
Sahajanand Medical Technologies Limited
Where
Blaricum, Breda, Dordrecht, Eindhoven, Leeuwarden, Rotterdam, and Terneuzen, NetherlandsSee the 7 sites
Trial code
Registry title
S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System
Status
Recruiting
People taking part
10,000 people, planned
Started
27 Feb 2018
Expected to end
Dec 2027
Type of study
Observational
Treatments tested
  • Supraflex Family Sirolimus-eluting Coronary Stent System
Record updated
23 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for adults with coronary artery disease whose doctor has planned to place at least one Supraflex Family stent as part of their normal care.

Age
18 years or older
Sex
All sexes can join.
Earlier treatment
The treating doctor has chosen to implant at least one Supraflex Family stent as part of planned care.

Main reasons for not taking part

  • Pregnant or breastfeeding women
  • High chance of not attending the follow-up visits
  • Taking part in another study that has not reached its main endpoint or that interferes with this registry
  • Planned surgery within 6 months of PCI, unless dual anti-platelet therapy continues throughout

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • The patient, or legal representative, has been informed of the nature of the registry and has consented to participate and authorised the collection and release of his/her medical information by signing a Patient Informed Consent Form
  • Treating physician has electively implanted at least one Supraflex Family stent as part of the patient's planned clinical care
  • The patient is willing and able to cooperate with study procedures and required follow up visits

Who cannot take part

  • Planned surgery within 6-month of PCI unless dual anti-platelet therapy is maintained throughout the peri-surgical period
  • Women with known pregnancy or who are lactating
  • High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
  • Currently participating in another study that has not completed the primary endpoint or that clinically interferes with the current registry requirements

Where in Netherlands

  • Tergooi ZiekenhuisBlaricum, NetherlandsContact: Vibhor BhatiaTaking people
  • Amphia ZiekenhuisBreda, NetherlandsContact: Vibhor BhatiaTaking people
  • Albert Schweitzer ZiekenhuisDordrecht, NetherlandsContact: Vibhor BhatiaTaking people
  • Catharina ZiekenhuisEindhoven, NetherlandsContact: Vibhor BhatiaTaking people
  • Medical Center LeeuwardenLeeuwarden, NetherlandsContact: Vibhor BhatiaTaking people
  • Maasstad ZiekenhuisRotterdam, NetherlandsContact: Vibhor BhatiaTaking people
  • ZorgSaam HospitalTerneuzen, NetherlandsContact: Vibhor BhatiaTaking people

About the trial

What the trial wants to find out

The primary objective of this registry is to evaluate the safety and efficacy of the Supraflex Family sirolimus-eluting coronary stent system in a 'real-world' patient population requiring stent implantation.

Treatments tested

  • Supraflex Family Sirolimus-eluting Coronary Stent System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System in a 'Real-World' Patient Population
Plain-language title
Studies a sirolimus-releasing stent in people with coronary artery diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
23 April 2026